Amgen Inc (AMGN) stock
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3023% above fair value
$438.82−5.07 (-1.14%)
Close on Nov 19, 2026Market cap $237.24BP/E 25.4Yield 2.20%
Amgen market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Amgen's market cap was $253.06B on Nov 11, 2026, against $186.03B a year earlier. Over the last 5 years it ranged from $117.89B to $253.06B, with a median of $152.79B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $253.06B | +43.6% |
| 2025 | Dec 31, 2025 | $176.26B | +25.8% |
| 2024 | Dec 31, 2024 | $140.09B | -9.1% |
| 2023 | Dec 29, 2023 | $154.12B | +10.0% |
| 2022 | Dec 30, 2022 | $140.12B | +10.2% |
| 2021 | Dec 31, 2021 | $127.11B | -5.3% |
| 2020 | Dec 31, 2020 | $134.16B | -7.6% |
| 2019 | Dec 31, 2019 | $145.15B | +14.9% |
| 2018 | Dec 31, 2018 | $126.34B | -0.0% |
| 2017 | Dec 29, 2017 | $126.36B | +16.0% |
| 2016 | Dec 30, 2016 | $108.90B | -11.1% |
| 2015 | Dec 31, 2015 | $122.54B | +1.1% |
| 2014 | Dec 31, 2014 | $121.16B | +40.8% |
| 2013 | Dec 31, 2013 | $86.03B | +29.9% |
| 2012 | Dec 31, 2012 | $66.21B | +10.5% |
| 2011 | Dec 30, 2011 | $59.91B | +14.6% |
| 2010 | Dec 31, 2010 | $52.26B | -9.1% |
| 2009 | Dec 31, 2009 | $57.48B | – |
See a number that looks wrong?